CompaniesByCap
EVH
Evolent Health Inc. (EVH)
NYSE · Healthcare

Evolent Health Inc. Revenue 2020–2025

Evolent Health Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Evolent Health Inc. revenue for the quarter ending March 31, 2026 was 496.2 M.
  • Evolent Health Inc. revenue for the twelve months ending March 31, 2026 was 1.9 B.
  • Evolent Health Inc. annual revenue for 2025 was 1.9 B, a 26.56% decrease from 2024.
  • Evolent Health Inc. annual revenue for 2024 was 2.6 B, a 30.09% increase from 2023.
  • Evolent Health Inc. annual revenue for 2023 was 2.0 B, a 45.26% increase from 2022.
  • Evolent Health Inc. annual revenue for 2022 was 1.4 B.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B

Evolent Health Inc. (EVH) — Frequently Asked Questions

Evolent Health Inc. (EVH) is a publicly traded US company. It has a market capitalization of $511M. In fiscal 2025 it reported revenue of $1.88B and net income of -$535M. Explore EVH's stock price, financial statements, earnings history, margins and key ratios below.

What is Evolent Health Inc.'s market cap?

Evolent Health Inc. (EVH) has a market capitalization of $511M.

What is the EVH stock price?

EVH trades at $4.47 (-5.30% on the day).

How much revenue does Evolent Health Inc. make?

Evolent Health Inc. reported revenue of $1.88B in fiscal 2025.

Is EVH profitable?

In fiscal 2025, Evolent Health Inc. reported net income of -$535M.

EVH Stock — Evolent Health Inc. Price, Earnings & Analysis | CompaniesByCap